Investment Thesis
Amylyx is in severe financial distress with zero revenue and -$37M quarterly operating cash burn despite a strong balance sheet. With $229.1M cash reserves, the company has approximately 18-24 months of runway at current burn rates, but faces imminent insolvency without revenue recovery or dramatic cost restructuring. The deterioration from prior periods signals fundamental business failure rather than temporary challenges.
Strengths
- Strong cash position of $229.1M with minimal debt (Debt/Equity 0.00x) providing near-term survival runway
- Solid balance sheet with $273.2M stockholders equity and only $20.4M total liabilities
- Exceptional liquidity ratios (17.85x current ratio) providing flexibility to address operational challenges
Risks
- Complete revenue collapse to $0 (down 100% YoY) indicating loss of primary commercial activity or major product discontinuation
- Negative operating cash flow of -$36.9M quarterly with company burning through cash reserves unsustainably
- Operating losses of -$43.8M and negative profitability metrics (ROE -15.1%, ROA -14.1%) indicating value destruction
- Limited runway of approximately 18-24 months before cash depletion at current burn rate
- No visibility to path to profitability or return to revenue generation
Key Metrics to Watch
- Quarterly revenue and gross profit recovery from current zero baseline
- Operating cash flow trend and monthly cash burn rate to assess runway accuracy
- Operating expense reduction, headcount changes, and restructuring initiatives
- Strategic alternatives including M&A activity, partnerships, or asset sales
Financial Metrics
Revenue
0.0
Net Income
-41.3M
EPS (Diluted)
$-0.37
Free Cash Flow
-37.0M
Total Assets
293.6M
Cash
229.1M
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
-15.1%
ROA
-14.1%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
17.85x
Quick Ratio
17.85x
Debt/Equity
0.00x
Debt/Assets
7.0%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T09:26:13.841038 |
Data as of: 2026-03-31 |
Powered by Claude AI